IMMUNIC, INC. Net Income Loss

• IMMUNIC, INC. showed an increase of +3.3% in Net Income Loss from 2024 to 2025.
• This data is from IMMUNIC, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 14 years of available data (2012 to 2025), IMMUNIC, INC.'s Net Income Loss has declined by 1,350.1%.
• Historical annual values: Fiscal year 2025: -$97.17 million | Fiscal year 2024: -$100.51 million | Fiscal year 2023: -$93.61 million | Fiscal year 2022: -$120.41 million | Fiscal year 2021: -$92.95 million | Fiscal year 2020: -$44.02 million | Fiscal year 2019: -$34.93 million | Fiscal year 2018: -$11.54 million | Fiscal year 2017: -$52.08 million | Fiscal year 2016: -$40.97 million | Fiscal year 2015: -$52.02 million | Fiscal year 2014: -$47.67 million | Fiscal year 2013: -$32.72 million | Fiscal year 2012: -$6.70 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026